VIROSYTE Trademark

Trademark Overview


On Tuesday, September 11, 2012, a trademark application was filed for VIROSYTE with the United States Patent and Trademark Office. The USPTO has given the VIROSYTE trademark a serial number of 85726152. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 18, 2013. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The VIROSYTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of inflammatory connective tissue diseases; development of pharmaceuticals for the treatment of gout, influenza and hepatitis; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma
virosyte

General Information


Serial Number85726152
Word MarkVIROSYTE
Filing DateTuesday, September 11, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 18, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2013

Trademark Statements


Goods and ServicesPharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of inflammatory connective tissue diseases; development of pharmaceuticals for the treatment of gout, influenza and hepatitis; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma
Pseudo MarkVIRO SYTE

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 17, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Monday, November 18, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 18, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 16, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 14, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 7, 2013ASSIGNED TO EXAMINER
Tuesday, September 18, 2012NOTICE OF PSEUDO MARK MAILED
Monday, September 17, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 14, 2012NEW APPLICATION ENTERED IN TRAM